植込み型心臓デバイスの世界市場レポート 2025年

植込み型心臓デバイス市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.7％で188億1,000万米ドルに成長します。予測期間の成長は、機器機能の技術的進歩、低侵襲処置の需要増加、高齢者人口の増加、ヘルスケア支出の増加、新興市場におけるヘルスケアインフラの拡大などに起因すると考えられます。予測期間の主な動向としては、デジタルヘルスと遠隔モニタリングの統合、機能強化された次世代機器の開発、個別化された患者別心臓ソリューションの成長、費用対効果と価値に基づくヘルスケアの重視、予防心臓学への注目の高まり、早期介入などが挙げられます。

心臓疾患の有病率の増加は、植込み型心臓デバイス市場の成長を促進すると予想されます。この増加は、不健康な食生活、座りがちなライフスタイル、肥満、糖尿病や高血圧などの慢性疾患など、いくつかの危険因子と関連している可能性があります。さらに、人口の高齢化とストレスレベルの上昇は、心血管問題の発生率の上昇に寄与しています。植込み型心臓デバイスは、心不全、不整脈、冠動脈疾患などの状態を管理・治療するために不可欠です。これらの機器に対するニーズの高まりは、拡大する患者集団の需要に応え、治療成績を向上させるために、新しく改良されたソリューションの開発に対する技術革新と投資を促進します。例えば、2024年5月、シンガポール心臓財団（SHF）は、虚血性心疾患による死亡者数は5,302人で、2022年の5,290人からわずかに増加したと報告しました。その結果、心臓病の罹患率の上昇が植込み型心臓デバイス市場の成長を促進しています。

植込み型心臓デバイス市場の主要企業は、機器の寿命を延ばし患者の安全性を高めるため、AutoMRIなどの診断ツールとの互換性向上に注力しています。植え込み型心臓除細動器のAutoMRI機能は、MRIスキャン中に安全な動作を確保するために機器の設定を自動的に調整するもので、これにより患者ケアを向上させながら高度なイメージング技術へのアクセスを容易にしています。例えば、2023年10月、フランスの医療機器メーカーであるMicroPort CRM社は、ULYS植込み型除細動器（ICD）とINVICTA除細動リードを日本で発売しました。これらの製品は、機器寿命の延長とMRIへの適合性を実現するために、低消費電流の先進技術を取り入れています。ULYS ICDはPARAD+不整脈識別アルゴリズムとAutoMRI機能を搭載し、INVICTAリードは正確なペーシングと除細動治療を提供し、臨床試験において植込み成功率100%、合併症無発症率97.4%を誇っています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界植込み型心臓デバイス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の植込み型心臓デバイス市場：成長率分析
• 世界の植込み型心臓デバイス市場の実績：規模と成長, 2019-2024
• 世界の植込み型心臓デバイス市場の予測：規模と成長, 2024-2029, 2034F
• 世界植込み型心臓デバイス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の植込み型心臓デバイス市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ペースメーカー
• 植込み型除細動器（ICD）
• 両室植込み型除細動器（BI-V ICD）
• 世界の植込み型心臓デバイス市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 徐脈
• 頻脈
• 心不全
• その他の用途
• 世界の植込み型心臓デバイス市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• その他のエンドユーザー
• 世界の植込み型心臓デバイス市場ペースメーカーのサブセグメンテーション：シングルチャンバーペースメーカー、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 短鎖イミダゾリンオリゴマー
• 長鎖イミダゾリンオリゴマー
• 液体肥料ソリューション
• 世界の植込み型心臓デバイス市場植込み型除細動器（ICD）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経静脈ICD
• 皮下ICD
• ウェアラブル除細動器
• 世界の植込み型心臓デバイス市場両室植込み型除細動器（BI-V ICD）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 標準BI-V ICD
• 心臓再同期療法（CRT）を備えた高度なBI-V ICD

第7章 地域別・国別分析

• 世界の植込み型心臓デバイス市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の植込み型心臓デバイス市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 植込み型心臓デバイス市場：競合情勢
• 植込み型心臓デバイス市場：企業プロファイル
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
  • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Boston Scientific Corporation
• B. Braun Melsungen AG
• Edwards Lifesciences Corporation
• Biotronik SE & Co. KG
• Zoll Medical Corporation
• Nihon Kohden Corporation
• LivaNova plc
• Lepu Medical Technology
• MicroPort Scientific Corporation
• AtriCure Inc.
• LifeTech Scientific Corporation
• Berlin Heart GmbH
• EBR Systems Inc.
• Defibtech LLC
• CVRx Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 植込み型心臓デバイス市場2029：新たな機会を提供する国
• 植込み型心臓デバイス市場2029：新たな機会を提供するセグメント
• 植込み型心臓デバイス市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Implantable cardiac devices are medical instruments that are surgically inserted into the body to assist in the management of heart disorders, especially those associated with irregular heart rhythms (arrhythmias) or heart failure. These devices monitor cardiac activity and often provide electrical impulses to regulate or correct abnormal heartbeats.

The primary categories of implantable cardiac devices consist of pacemakers, implantable cardioverter defibrillators (ICDs), and biventricular implantable cardioverter defibrillators (BI-V ICDs). A pacemaker is a compact medical device positioned beneath the skin in the chest area, designed to manage irregular heartbeats by delivering electrical impulses that prompt the heart to maintain a normal rhythm when its natural pacemaker is inadequate. This device is essential in treating conditions such as bradycardia and various arrhythmias. Applications for these devices encompass bradycardia, tachycardia, heart failure, among others, catering to end users such as hospitals, specialty clinics, and more.

The implantable cardiac devices market research report is one of a series of new reports from the business research company that provides implantable cardiac devices market statistics, including implantable cardiac devices industry global market size, regional shares, competitors with an implantable cardiac devices market share, detailed implantable cardiac devices market segments, market trends and opportunities, and any further data you may need to thrive in the implantable cardiac devices industry. This implantable cardiac devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The implantable cardiac devices market size has grown strongly in recent years. It will grow from $12.34 billion in 2024 to $13.46 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to advances in medical technology, increasing prevalence of cardiovascular diseases, growing aging population, improvements in device reliability and longevity, rising awareness, and early diagnosis of heart conditions.

The implantable cardiac devices market size is expected to see strong growth in the next few years. It will grow to $18.81 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to technological advancements in device functionality, increasing demand for minimally invasive procedures, growing geriatric population, rising healthcare expenditures, and expansion of healthcare infrastructure in emerging markets. Major trends in the forecast period include integration of digital health and remote monitoring, development of next-generation devices with enhanced features, growth in personalized and patient-specific cardiac solutions, emphasis on cost-effectiveness and value-based healthcare, increasing focus on preventive cardiology, and early intervention.

The increasing prevalence of heart diseases is expected to drive the growth of the implantable cardiac devices market. This rise can be linked to several risk factors, including unhealthy diets, sedentary lifestyles, obesity, and chronic conditions such as diabetes and hypertension. Furthermore, aging populations and elevated stress levels contribute to the higher incidence of cardiovascular issues. Implantable cardiac devices are essential for managing and treating conditions such as heart failure, arrhythmias, and coronary artery disease. The growing need for these devices fosters innovation and investment in the development of new and improved solutions to meet the demands of an expanding patient population and enhance treatment outcomes. For example, in May 2024, the Singapore Heart Foundation (SHF) reported that ischemic heart disease led to 5,302 deaths, a slight increase from 5,290 deaths in 2022. Consequently, the rising incidence of heart disease is propelling the growth of the implantable cardiac devices market.

Key companies in the implantable cardiac devices market are concentrating on improving compatibility with diagnostic tools, such as AutoMRI, to extend device lifespan and enhance patient safety. The AutoMRI feature in implantable cardiac defibrillators automatically adjusts device settings to ensure safe operation during MRI scans, thereby facilitating access to advanced imaging technology while enhancing patient care. For instance, in October 2023, MicroPort CRM, a France-based medical device company, launched the ULYS implantable cardioverter defibrillator (ICD) and INVICTA defibrillation leads in Japan. These products incorporate advanced technology with low current consumption for extended device lifespan and MRI compatibility. The ULYS ICD features the PARAD+ arrhythmia discrimination algorithm and AutoMRI functionality, while the INVICTA lead provides precise pacing and defibrillation therapy, boasting a 100% implantation success rate and a 97.4% complication-free rate in clinical trials.

In February 2022, Genesis MedTech Group, a Singapore-based medical device manufacturer, acquired JC Medical (JCM) for an undisclosed amount. This acquisition aims to enhance Genesis's product portfolio by adding the J-Valve, a minimally invasive transcatheter aortic valve replacement (TAVR) device designed for patients with aortic regurgitation and stenosis. JC Medical (JCM) is a U.S.-based manufacturer specializing in structural heart devices and cardiac implants.

Major companies operating in the implantable cardiac devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, Biotronik SE & Co. KG, Zoll Medical Corporation, Nihon Kohden Corporation, LivaNova plc, Lepu Medical Technology, MicroPort Scientific Corporation, AtriCure Inc., LifeTech Scientific Corporation, Berlin Heart GmbH, EBR Systems Inc., Defibtech LLC, CVRx Inc., Progetti Srl, Endotronix Inc., Jarvik Heart Inc., Xeltis AG, Carmat SA, Windmill Cardiovascular Systems Inc

North America was the largest region in the implantable cardiac devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable cardiac devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the implantable cardiac devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The implantable cardiac devices market consists of sales of products including cardiac resynchronization therapy (CRT) devices, ventricular assist devices (VADs), and implantable heart monitors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Cardiac Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable cardiac devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable cardiac devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The implantable cardiac devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Pacemaker; Implantable Cardioverter Defibrillator (ICD); Biventricular Implantable Cardioverter Defibrillator (BI-V ICD)
• 2) By Application: Bradycardia; Tachycardia; Heart Failure; Other Applications
• 3) By End User: Hospitals; Specialty Clinics; Other End Users
• Subsegments:
• 1) By Pacemaker: Single-Chamber Pacemakers; Dual-Chamber Pacemakers; Rate-Responsive Pacemakers
• 2) By Implantable Cardioverter Defibrillator (ICD): Transvenous ICDs; Subcutaneous ICDs; Wearable Cardioverter Defibrillators
• 3) By Biventricular Implantable Cardioverter Defibrillator (BI-V ICD): Standard BI-V ICDs; Advanced BI-V ICDs with Cardiac Resynchronization Therapy (CRT)
• Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic plc; Koninklijke Philips N.V.; Stryker Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Implantable Cardiac Devices Market Characteristics

3. Implantable Cardiac Devices Market Trends And Strategies

4. Implantable Cardiac Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Implantable Cardiac Devices Growth Analysis And Strategic Analysis Framework

• 5.1. Global Implantable Cardiac Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Implantable Cardiac Devices Market Growth Rate Analysis
• 5.4. Global Implantable Cardiac Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Implantable Cardiac Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Implantable Cardiac Devices Total Addressable Market (TAM)

6. Implantable Cardiac Devices Market Segmentation

• 6.1. Global Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pacemaker
• Implantable Cardioverter Defibrillator (ICD)
• Biventricular Implantable Cardioverter Defibrillator (BI-V ICD)
• 6.2. Global Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bradycardia
• Tachycardia
• Heart Failure
• Other Applications
• 6.3. Global Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Other End Users
• 6.4. Global Implantable Cardiac Devices Market, Sub-Segmentation Of Pacemaker: Single-Chamber Pacemakers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Short-Chain Imidazoline Oligomers
• Long-Chain Imidazoline Oligomers
• Liquid Fertilizer Solutions
• 6.5. Global Implantable Cardiac Devices Market, Sub-Segmentation Of Implantable Cardioverter Defibrillator (ICD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transvenous ICDs
• Subcutaneous ICDs
• Wearable Cardioverter Defibrillators
• 6.6. Global Implantable Cardiac Devices Market, Sub-Segmentation Of Biventricular Implantable Cardioverter Defibrillator (BI-V ICD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard BI-V ICDs
• Advanced BI-V ICDs with Cardiac Resynchronization Therapy (CRT)

7. Implantable Cardiac Devices Market Regional And Country Analysis

• 7.1. Global Implantable Cardiac Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Implantable Cardiac Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Implantable Cardiac Devices Market

• 8.1. Asia-Pacific Implantable Cardiac Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Implantable Cardiac Devices Market

• 9.1. China Implantable Cardiac Devices Market Overview
• 9.2. China Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Implantable Cardiac Devices Market

• 10.1. India Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Implantable Cardiac Devices Market

• 11.1. Japan Implantable Cardiac Devices Market Overview
• 11.2. Japan Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Implantable Cardiac Devices Market

• 12.1. Australia Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Implantable Cardiac Devices Market

• 13.1. Indonesia Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Implantable Cardiac Devices Market

• 14.1. South Korea Implantable Cardiac Devices Market Overview
• 14.2. South Korea Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Implantable Cardiac Devices Market

• 15.1. Western Europe Implantable Cardiac Devices Market Overview
• 15.2. Western Europe Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Implantable Cardiac Devices Market

• 16.1. UK Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Implantable Cardiac Devices Market

• 17.1. Germany Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Implantable Cardiac Devices Market

• 18.1. France Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Implantable Cardiac Devices Market

• 19.1. Italy Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Implantable Cardiac Devices Market

• 20.1. Spain Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Implantable Cardiac Devices Market

• 21.1. Eastern Europe Implantable Cardiac Devices Market Overview
• 21.2. Eastern Europe Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Implantable Cardiac Devices Market

• 22.1. Russia Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Implantable Cardiac Devices Market

• 23.1. North America Implantable Cardiac Devices Market Overview
• 23.2. North America Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Implantable Cardiac Devices Market

• 24.1. USA Implantable Cardiac Devices Market Overview
• 24.2. USA Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Implantable Cardiac Devices Market

• 25.1. Canada Implantable Cardiac Devices Market Overview
• 25.2. Canada Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Implantable Cardiac Devices Market

• 26.1. South America Implantable Cardiac Devices Market Overview
• 26.2. South America Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Implantable Cardiac Devices Market

• 27.1. Brazil Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Implantable Cardiac Devices Market

• 28.1. Middle East Implantable Cardiac Devices Market Overview
• 28.2. Middle East Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Implantable Cardiac Devices Market

• 29.1. Africa Implantable Cardiac Devices Market Overview
• 29.2. Africa Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Implantable Cardiac Devices Market Competitive Landscape And Company Profiles

• 30.1. Implantable Cardiac Devices Market Competitive Landscape
• 30.2. Implantable Cardiac Devices Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Implantable Cardiac Devices Market Other Major And Innovative Companies

• 31.1. Boston Scientific Corporation
• 31.2. B. Braun Melsungen AG
• 31.3. Edwards Lifesciences Corporation
• 31.4. Biotronik SE & Co. KG
• 31.5. Zoll Medical Corporation
• 31.6. Nihon Kohden Corporation
• 31.7. LivaNova plc
• 31.8. Lepu Medical Technology
• 31.9. MicroPort Scientific Corporation
• 31.10. AtriCure Inc.
• 31.11. LifeTech Scientific Corporation
• 31.12. Berlin Heart GmbH
• 31.13. EBR Systems Inc.
• 31.14. Defibtech LLC
• 31.15. CVRx Inc.

32. Global Implantable Cardiac Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Implantable Cardiac Devices Market

34. Recent Developments In The Implantable Cardiac Devices Market

35. Implantable Cardiac Devices Market High Potential Countries, Segments and Strategies

• 35.1 Implantable Cardiac Devices Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Implantable Cardiac Devices Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Implantable Cardiac Devices Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer